Moneytize is a trading education company that provides courses in Forex, Crypto, and Stock trading for beginners, intermediate, and advanced traders, with a focus on enhancing trading skills and financial literacy.

Moneytize

Udemy, Inc. operates a marketplace platform for teaching and learning skills in the United States and internationally. The company offers technical and business skills, and personal development courses for individual learners and enterprise customers. Its platform provides 49 million learners with access to approximately 180,000 courses through direct-to-consumer or Udemy Business offerings in approximately 75 languages. The company's courses offer learning objectives, such as reskilling or upskilling in technology and business, and soft skills, as well as learners receive access to interactive learning tools comprising quizzes, exercises, and instructor questions-and-answers. Udemy, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Eren Bali

Gagan Biyani

Oktay Caglar

Udemy, Inc.

Vittoria Biotherapeutics is committed to unlocking the promise of cell therapies while addressing their inherent challenges by strengthening efficacy, improving safety, and broadening therapeutic applicability for patients with difficult-to-treat diseases.

Metric
Company Name	Moneytize	Udemy, Inc.	Vittoria Biotherapeutics
Symbol		UDMY
MSH ID	AE:MONEYTIZE	COM:UDEMY	COM:VITTORIABIO
Market	PRIVATE	STOCKS	PRIVATE
Sector	Commercial & Professional Services	Consumer Defensive	Healthcare & Health Services
Industry	Education & Training	Education & Training Services	Biotechnology Research
Country	AE	US	US
Stage		Venture
Employee Count		1.44K	11
Website	moneytize.ae	udemy.com	vittoriabio.com
LinkedIn		udemy	vittoriabio
Founders

Metric
Market Cap	1.24B	40M
Enterprise Value
Monthly Web Traffic	111.45M
Web Traffic Growth	0.03
Valuation
Raised Capital	4.40M

Metric
Revenue		728.94M
Revenue (LTM)
Revenue (NTM)
Gross Profit		418.13M
EBITDA		-87.04M
Operating Income		-111.63M
Net Income		-107.29M
EPS		-0.71
Diluted EPS		-0.71
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.60
Operating Profit Margin		-0.12
EBITDA Margin		-0.12
Net Profit Margin		-0.11
Return on Equity		-0.24
Return on Assets		-0.11
Return on Capital Employed		-0.31

AE:MONEYTIZE

Moneytize

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-15.04
P/B Ratio		6.05
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		2.41
EV Multiple		-22.40

Metric
Days Sales Outstanding		42.91
Days Payables Outstanding		6.80
Days Inventory Outstanding		0.00
Operating Cycle		48.59
Cash Conversion Cycle		44.97
Asset Turnover		1.14

Metric
Operating Cash Flow		-2.00M
Free Cash Flow		-15.07M
Cash Flow to Debt		8.59
Operating Cash Flow/Sales		0.07
Free Cash Flow Yield		-0.02

Metric
Cash & Equivalents		308.89M
Accounts Receivable		10.31M
Inventory
Goodwill		12.65M
Debt to Capitalization		0.05
Debt to Assets		0.01
Current Ratio		1.61
Quick Ratio		1.51

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.14
R&D to Revenue		0.17
SG&A to Revenue		0.15